Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Pegylated liposomal formulations of apelin for treatment of cardiovascular-related diseases

Pegylated liposomal formulations of apelin for treatment of cardiovascular-related diseases

US Patent 11400049 · Granted Aug 2, 2022

Assignee

No assignee recorded.

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Controlled hydrogel delivery of focal adhesion kinase inhibitor for decreased sc2024
Efficient stem cell delivery into biomaterials using capillary driven encapsulat2021
Topical and transdermal delivery of HIF-1 modulators to prevent and treat chroni2021
Threads of hyaluronic acid and/or derivatives thereof, methods of making thereof2021
Microneedle patches for transdermal delivery2021
Topical and transdermal delivery of HIF-1 modulators to prevent and treat chroni2020
HIF-1 modulator paint formulation and uses thereof2020
Nanogrid electrochemical sensor for detection of biochemical species by electroc2020
Threads of hyaluronic acid and/or derivatives thereof, methods of making thereof2019
Methods of testing for allergen sensitivity2019
4-methylumbelliferone derivatives for treatment for immune modulation2019
HIF-1 modulator paint formulation and uses thereof2019